News
Investment in research essential for effective healthcare: International Clinical Trials Day 2011
Sustainable healthcare requires long-term commitment to health research. Investment in research will provide the scientific knowledge and evidence needed to inform health policies and to…
HIV Vaccine Awareness Day 2011
18 May is HIV Vaccine Awareness Day, a day to recognise the efforts of healthy volunteers, patients, community educators, healthcare professionals and scientists in the…
Uganda: first vaccination for GMZ2 malaria vaccine trial
Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the…
Willem Hanekom: Inaugural Lecture on Vaccines to prevent TB
Professor Willem Hanekom will give his inaugural lecture as Professor of Clinical Immunology at the University of Cape Town, South Africa later today. He will…
Burkina Faso: GMZ2 malaria vaccine trial recruiting first patients
Recruitment of the first patients for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 has started in the Burkina Faso trial site…
Accordia 2011 Health Leadership Award to Dr Christian Happi (Nigeria)
On 25 April 2011, World Malaria Day, Accordia Global Health Foundation announced that Dr Christian Happi from the University of Ibadan in Nigeria has won…
World Malaria Day on 25 April: Urgent call for research to meet drug resistance challenge
Since 2007 an increase in malaria control and prevention has saved many lives. World Malaria Day on 25 April 2011 aims to acknowledge this achievement…
Diagnostic test Xpert MTB/RIF proven fast and effective in low-resource settings
The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test…
EAC Health Ministers sixth annual meeting in the Republic of Burundi: participation in EDCTP programme encouraged
The Ministers of Health of the East African Community, Permanent Secretaries and Senior government officials responsible for policies on health, research and regulatory issues convened…
World Tuberculosis Day 2011: EDCTP contributes to fill research gaps
The European and Developing Countries Clinical Trials Partnership (EDCTP) fully supports the ambition of the international Stop TB Partnership to transform the fight for the…
International Women’s Day 2011: EDCTP hails the contribution of women to its clinical trial projects
The European and Developing Countries Clinical Trials Partnership (EDCTP) celebrates the 100th International Women’s Day by honouring the contribution of women, in all capacities in…
G-FINDER 2010 shows change of focus on R&D funding
The third annual G-FINDER survey, the most comprehensive report to date on public and private funding into research and development (R&D) for neglected diseases, was…
TB drug candidate SQ109 in the top five most promising Q1 drugs entering phase II trials
Thomson Reuters reports on most promising drugs changing clinical phase in the first quarter of 2011. The SQ109, a novel anti-TB drug candidate that could…
AMANET announces good progress of the Phase 2 Clinical Trial of Candidate Malaria Vaccine GMZ2 in Gabon
The African Malaria Network Trust (AMANET) and the consortium investigating the efficacy of malaria vaccine candidate GMZ2 proudly announce the good progress of the GMZ2…
Kesho Bora study results offer new hope for mother-to-child transmission of HIV during breastfeeding
A new study published in Lancet Infectious Diseases of 14 January 2011 shows that giving a triple antiretroviral therapy (ART) during pregnancy, delivery and breastfeeding…